Actively Recruiting
Pilot Study of Low-Dose CT Screening for Lung Cancer in High-Risk Adults in Kuwait to Assess Feasibility and Screening Uptake
Led by Sulaiman Khadadah · Updated on 2026-11-03
590
Participants Needed
1
Research Sites
91 weeks
Total Duration
AI-Summary
What This Trial Is About
Lung cancer is a major cause of cancer-related death in Kuwait, where most cases are detected at advanced stages and no national screening program currently exists. This prospective pilot feasibility study aims to assess the acceptance and challenges of low-dose computed tomography LDCT lung cancer screening among high-risk adults aged 50 to 80 years. The goal is to develop a foundation for a future national screening program. Participants are recruited at Ministry of Health polyclinics and hospital chest clinics, with screening conducted at the Chest Diseases Hospital. Each participant undergoes eligibility and baseline assessments before being offered three LDCT screening rounds one at enrollment and two annual follow-ups. The Lung-RADS system guides management, including annual screening for low-risk categories, short-interval CT scans for moderate risk, and immediate referral for high-risk findings. Radiologists interpret the scans without artificial intelligence during the study AI analysis will be performed later on archived scans. Participants will complete baseline and annual LDCT scans with follow-up based on Lung-RADS results. Researchers will measure consent rates, scan completion, screening barriers, lung cancer detection rates, and participant experiences over approximately 24 months. Additional assessments include radiation exposure, incidental findings, adherence to follow-up, and AI software performance in a separate reader study. This comprehensive monitoring aims to inform Kuwaits lung cancer screening guidelines and improve early detection.
CONDITIONS
Brief Title
Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in Kuwait
Research Team
S
Sulaiman Khadadah, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here